Know Cancer

or
forgot password

A SU011248 Expanded Access Protocol for Metastatic RCC Patients Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248


N/A
18 Years
85 Years
Open (Enrolling)
Both
Metastatic Renal Cell Carcinoma

Thank you

Trial Information

A SU011248 Expanded Access Protocol for Metastatic RCC Patients Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248


Inclusion Criteria:



- Patients with metastatic Renal Cell Carcinoma who are ineligible for participation in
other SU011248 protocols but may derive benefit from treatment with SU011248

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Efficacy

Outcome Time Frame:

2001-2012

Safety Issue:

No

Principal Investigator

Shouki Bazarbashi, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

KFSH&RC, Riyadh, Saudi Arabia

Authority:

ORA: KFSH&RC, Riyadh, Saudi Arabia

Study ID:

RAC#2061 043

NCT ID:

NCT00531544

Start Date:

February 2007

Completion Date:

June 2012

Related Keywords:

  • Metastatic Renal Cell Carcinoma
  • Carcinoma
  • Carcinoma, Renal Cell

Name

Location